Alzex Neuropharma is a drug discovery research company dedicated to the design of safe Brain targeting molecules for a variety of Brain diseases. The Company has a unique way of delivering drugs to the brain efficiently without serious and debilitating side effects. Their scientific team has discovered and patented a brand new chemical structure which allows the Bioprecursor to deliver drugs through the Blood Brain Barrier before initiating any biological activity, without severe side effects. Completed R&D studies have already demonstrated technical proof of concept in initial “in-vitro “and “in-vivo”models. Other neurological applications are ongoing for further development.

Alzex’s patented bioprecursor has proven its ability to safely penetrate the Blood Brain Barrier, while leaving healthy cells unharmed.